A combined risk score using genetic and clinical factors improves PF prediction in RA patients, outperforming clinical factors alone. Genetic markers MUC5B and FAM13A are significantly associated with ...
This study aims to improve survival modeling in head and neck cancer (HNC) by integrating patient-reported outcomes (PROs) using dimensionality reduction techniques. PROs capture symptom severity ...
Only about one in five people with cancer enroll in clinical trials, and the largest barrier to participation may be far ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback